Monday

18th Mar 2019

Something 'rotten' in EU pharmaceutical sector, says Kroes

  • The commission report points to widespread collusion between European drug makers (Photo: www.freeimages.co.uk)

European competition commissioner Neelie Kroes turned to Shakespeare on Wednesday (8 July) to describe anti-competition practices being widely used by pharmaceutical companies throughout the European union.

"Overall it is indeed a conclusion that there is something rotten in the state," she said, paraphrasing comments made by the character Marcellus in Act I of the British playwright's famous work, Hamlet.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 18 year's of archives. 30 days free trial.

... or join as a group

Ms Kroes made the statement following the publication of a final inquiry report on Europe's pharmaceutical sector – a document that points to widespread collusion between drug companies producing original products and others producing generic copies.

According to the report, a considerable number of generic drug producers have accepted payments to delay the release of medicines that are on average 40 percent cheaper than the original product two years after its initial release.

Sending a clear signal that it means to crack down on the practice that results in European citizens paying more for their medicines, the commission has opened a formal antitrust investigation against French company Les Laboratoires Servier and a number of generic drug producers suspected of collusion.

"When it comes to generic entry, every week and month of delay costs money to patients and taxpayers. We will not hesitate to apply the antitrust rules where such delays result from anticompetitive practices," said Ms Kroes.

The case, the first of its kind, surrounds the production of a generic form of perindopril, a cardiovascular medicine used to prevent heart disease and lower blood pressure originally developed by Servier.

The commission says it has evidence of a least a further 200 incidences of illegal agreements between European drug companies, all of which could lead to fines if sufficient evidence is found.

"We hoped to get out a case that is really damaging," said Ms Kroes when asked why the commission had concentrated its first case on Servier and not on other suspected companies, some of which are considerably bigger.

The debate over artificially inflated drug prices is particularly relevant at present as Europe's population grows older and the prospects for both private and public pensions look shakier due to the financial crisis.

"With the ageing population we are going to need more medicine," said Ms Kroes.

European citizens currently spend €214 billion per year on pharmaceuticals, equivalent to 2 percent of the bloc's total GDP or €430 per year per citizen.

The commission report also calls on member states to introduce legislation to facilitate the uptake of generic drugs and says a community patent and specialised patent litigation system in Europe is now more necessary than ever.

At present 30 percent of patent court cases are conducted in parallel in several member states, and in 11 percent of cases national courts reach conflicting judgements.

Opinion

Why are our medicines so expensive?

The EU should be promoting open innovation in upcoming trade talks with India and should work to bring down the prices of essential medicines, both abroad and within its borders.

Magazine

The changing of the guards in the EU in 2019

The four most powerful EU institutions - Commission, Parliament, Council and Central Bank will all have new leaders in the coming ten months. Here is an overview.

Agenda

Brexit delay and Orban decision This WEEK

EU leaders will discuss whether to allow London to delay its exit from the bloc, as some are worried it would mean more of the same. Meantime, the European People's Party braces itself for a showdown with Hungary's Orban.

Opinion

EU must get real on Russia

The EU must call the Ukraine conflict by its true name - Russia's illegal war on its peaceful neighbour - and take commensurate action to protect peace in Europe.

News in Brief

  1. Third Brexit vote this week only if DUP will support it
  2. Germany's two largest banks confirm merger talks
  3. Serbian pro-democracy protests reach 15th week
  4. 'Yellow Vest' riots leave Paris shops vandalised
  5. European woman older when having first baby
  6. Majority of Germans want Merkel to stay on
  7. Asylum applications in the EU down to 580,800 in 2018
  8. Children's climate school strikes turn global on Friday

Magazine

All about the European Parliament elections 2019

EUobserver's new magazine is meant to help readers prepare for the European Parliament elections, no matter their level of knowledge. You can download and read the entire magazine now.

Stakeholders' Highlights

  1. Nordic Council of MinistersNew Secretary General: Nordic co-operation must benefit everybody
  2. Platform for Peace and JusticeMEP Kati Piri: “Our red line on Turkey has been crossed”
  3. UNICEF2018 deadliest year yet for children in Syria as war enters 9th year
  4. Nordic Council of MinistersNordic commitment to driving global gender equality
  5. International Partnership for Human RightsMeet your defender: Rasul Jafarov leading human rights defender from Azerbaijan
  6. UNICEFUNICEF Hosts MEPs in Jordan Ahead of Brussels Conference on the Future of Syria
  7. Nordic Council of MinistersNordic talks on parental leave at the UN
  8. International Partnership for Human RightsTrial of Chechen prisoner of conscience and human rights activist Oyub Titiev continues.
  9. Nordic Council of MinistersNordic food policy inspires India to be a sustainable superpower
  10. Nordic Council of MinistersMilestone for Nordic-Baltic e-ID
  11. Counter BalanceEU bank urged to free itself from fossil fuels and take climate leadership
  12. Intercultural Dialogue PlatformRoundtable: Muslim Heresy and the Politics of Human Rights, Dr. Matthew J. Nelson

Join EUobserver

Support quality EU news

Join us